Malignant neoplasm of ovary
Chapter 2:Neoplasms
ICD-10 C56 is a billable code used to indicate a diagnosis of malignant neoplasm of ovary.
Malignant neoplasm of the ovary, classified under ICD-10 code C56, refers to cancerous tumors that originate in the ovarian tissue. This condition is a significant concern in gynecologic oncology, as ovarian cancer often presents at an advanced stage due to vague symptoms in early stages. The neoplasm can be classified into various histological types, including serous, mucinous, endometrioid, and clear cell carcinomas. Staging of ovarian cancer is crucial for determining treatment options and prognosis, typically following the FIGO (International Federation of Gynecology and Obstetrics) staging system, which ranges from Stage I (confined to the ovaries) to Stage IV (distant metastasis). CA-125, a tumor marker, is often utilized in the diagnosis and monitoring of ovarian cancer, although it is not specific and can be elevated in other conditions. Surgical approaches, including total abdominal hysterectomy with bilateral salpingo-oophorectomy (TAH-BSO) and debulking surgery, are common treatment modalities, often followed by chemotherapy. Accurate coding for C56 requires thorough documentation of the tumor type, stage, and treatment plan.
Detailed pathology reports, imaging studies, surgical notes, and treatment plans.
Diagnosis of ovarian cancer, staging workup, and treatment planning.
Ensure accurate staging and documentation of tumor markers for appropriate coding.
Comprehensive histopathological reports and tumor grading.
Evaluation of ovarian biopsy specimens and surgical pathology.
Clear differentiation of tumor types and documentation of staging.
Performed for staging and treatment of ovarian cancer.
Operative report detailing the procedure and findings.
Ensure alignment with gynecologic oncology standards.
CA-125 is a tumor marker that can be elevated in ovarian cancer. It is used for diagnosis, monitoring treatment response, and detecting recurrence, but it is not specific to ovarian cancer and can be elevated in other conditions.
